

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.94972827 |
| 2 | presynaptic membrane assembly (GO:0097105) | 5.27749903 |
| 3 | negative regulation of telomere maintenance (GO:0032205) | 5.09330274 |
| 4 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.04104512 |
| 5 | vocalization behavior (GO:0071625) | 4.95483381 |
| 6 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.85048282 |
| 7 | presynaptic membrane organization (GO:0097090) | 4.75753983 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.74154899 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.70296485 |
| 10 | DNA damage induced protein phosphorylation (GO:0006975) | 4.68120972 |
| 11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.60924488 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 4.60724956 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.51186851 |
| 14 | protein polyglutamylation (GO:0018095) | 4.39137528 |
| 15 | protein localization to synapse (GO:0035418) | 4.34858641 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.30924343 |
| 17 | synaptic transmission, glutamatergic (GO:0035249) | 4.30901916 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.24019314 |
| 19 | postsynaptic membrane organization (GO:0001941) | 4.17999318 |
| 20 | neuron-neuron synaptic transmission (GO:0007270) | 4.16253337 |
| 21 | startle response (GO:0001964) | 4.13570239 |
| 22 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.03766638 |
| 23 | regulation of telomere maintenance (GO:0032204) | 4.03206558 |
| 24 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.98697720 |
| 25 | locomotory exploration behavior (GO:0035641) | 3.96312760 |
| 26 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.89953484 |
| 27 | neuron recognition (GO:0008038) | 3.87810822 |
| 28 | negative regulation of telomerase activity (GO:0051974) | 3.83194793 |
| 29 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.79398684 |
| 30 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.76779230 |
| 31 | behavioral response to nicotine (GO:0035095) | 3.76598857 |
| 32 | neuronal action potential propagation (GO:0019227) | 3.73846428 |
| 33 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.69092682 |
| 34 | neuronal action potential (GO:0019228) | 3.68499532 |
| 35 | regulation of helicase activity (GO:0051095) | 3.67591712 |
| 36 | synaptic vesicle exocytosis (GO:0016079) | 3.66924037 |
| 37 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.66192615 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.64770590 |
| 39 | transmission of nerve impulse (GO:0019226) | 3.64314394 |
| 40 | epithelial cilium movement (GO:0003351) | 3.61683701 |
| 41 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.61413543 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.57657966 |
| 43 | C4-dicarboxylate transport (GO:0015740) | 3.55011295 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.43148131 |
| 45 | regulation of postsynaptic membrane potential (GO:0060078) | 3.42406212 |
| 46 | response to histamine (GO:0034776) | 3.38011708 |
| 47 | serotonin metabolic process (GO:0042428) | 3.34776290 |
| 48 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.34390840 |
| 49 | long-term memory (GO:0007616) | 3.34155757 |
| 50 | positive regulation of synapse assembly (GO:0051965) | 3.33497930 |
| 51 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.33154751 |
| 52 | brain morphogenesis (GO:0048854) | 3.31506371 |
| 53 | L-amino acid import (GO:0043092) | 3.30713873 |
| 54 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.30369903 |
| 55 | exploration behavior (GO:0035640) | 3.29728509 |
| 56 | central nervous system myelination (GO:0022010) | 3.28564258 |
| 57 | axon ensheathment in central nervous system (GO:0032291) | 3.28564258 |
| 58 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.28223299 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.27268629 |
| 60 | axonal fasciculation (GO:0007413) | 3.27193960 |
| 61 | response to auditory stimulus (GO:0010996) | 3.25832866 |
| 62 | glutamate secretion (GO:0014047) | 3.25114790 |
| 63 | negative regulation of neurotransmitter transport (GO:0051589) | 3.24188030 |
| 64 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.20990957 |
| 65 | adult walking behavior (GO:0007628) | 3.20944546 |
| 66 | long-term synaptic potentiation (GO:0060291) | 3.19356007 |
| 67 | interkinetic nuclear migration (GO:0022027) | 3.18112641 |
| 68 | cilium movement (GO:0003341) | 3.17647672 |
| 69 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.15906651 |
| 70 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.15758270 |
| 71 | response to pheromone (GO:0019236) | 3.15568880 |
| 72 | central nervous system neuron axonogenesis (GO:0021955) | 3.14550075 |
| 73 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.12429693 |
| 74 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.11952333 |
| 75 | cerebellar granule cell differentiation (GO:0021707) | 3.11373906 |
| 76 | primary amino compound metabolic process (GO:1901160) | 3.11362079 |
| 77 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.10374280 |
| 78 | membrane depolarization (GO:0051899) | 3.09842710 |
| 79 | neurotransmitter secretion (GO:0007269) | 3.09815859 |
| 80 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.07902111 |
| 81 | reflex (GO:0060004) | 3.07756227 |
| 82 | dendritic spine morphogenesis (GO:0060997) | 3.07624082 |
| 83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.07605875 |
| 84 | membrane hyperpolarization (GO:0060081) | 3.06314118 |
| 85 | behavioral fear response (GO:0001662) | 3.04821680 |
| 86 | behavioral defense response (GO:0002209) | 3.04821680 |
| 87 | behavioral response to ethanol (GO:0048149) | 3.03768196 |
| 88 | auditory behavior (GO:0031223) | 3.02122507 |
| 89 | synapse assembly (GO:0007416) | 3.01492893 |
| 90 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.01404868 |
| 91 | detection of light stimulus involved in visual perception (GO:0050908) | 3.01404868 |
| 92 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.99828569 |
| 93 | regulation of respiratory system process (GO:0044065) | 2.99164856 |
| 94 | synaptic vesicle maturation (GO:0016188) | 2.99104996 |
| 95 | establishment of protein localization to Golgi (GO:0072600) | 2.98333887 |
| 96 | learning (GO:0007612) | 2.95384335 |
| 97 | regulation of synapse assembly (GO:0051963) | 2.95178474 |
| 98 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.93516950 |
| 99 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.92222390 |
| 100 | nucleobase catabolic process (GO:0046113) | 2.90785149 |
| 101 | axoneme assembly (GO:0035082) | 2.89991971 |
| 102 | regulation of synaptic vesicle transport (GO:1902803) | 2.88745737 |
| 103 | mechanosensory behavior (GO:0007638) | 2.88120511 |
| 104 | retinal ganglion cell axon guidance (GO:0031290) | 2.87380175 |
| 105 | synaptic vesicle endocytosis (GO:0048488) | 2.87277828 |
| 106 | cilium morphogenesis (GO:0060271) | 2.87004179 |
| 107 | membrane depolarization during action potential (GO:0086010) | 2.84171192 |
| 108 | indole-containing compound catabolic process (GO:0042436) | 2.83757676 |
| 109 | indolalkylamine catabolic process (GO:0046218) | 2.83757676 |
| 110 | tryptophan catabolic process (GO:0006569) | 2.83757676 |
| 111 | regulation of synaptic plasticity (GO:0048167) | 2.83385189 |
| 112 | fear response (GO:0042596) | 2.83214171 |
| 113 | neurotransmitter transport (GO:0006836) | 2.83167212 |
| 114 | amino acid import (GO:0043090) | 2.83128289 |
| 115 | nonmotile primary cilium assembly (GO:0035058) | 2.80823418 |
| 116 | regulation of glutamate secretion (GO:0014048) | 2.80663103 |
| 117 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.77093344 |
| 118 | regulation of synapse structural plasticity (GO:0051823) | 2.76793681 |
| 119 | regulation of cilium movement (GO:0003352) | 2.76416490 |
| 120 | lymphangiogenesis (GO:0001946) | 2.76219692 |
| 121 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.75662058 |
| 122 | regulation of respiratory gaseous exchange (GO:0043576) | 2.75565837 |
| 123 | protein localization to cilium (GO:0061512) | 2.75485050 |
| 124 | dendrite morphogenesis (GO:0048813) | 2.75367278 |
| 125 | righting reflex (GO:0060013) | 2.74736980 |
| 126 | neurofilament cytoskeleton organization (GO:0060052) | 2.74394787 |
| 127 | regulation of dendritic spine development (GO:0060998) | 2.74247634 |
| 128 | cyclic nucleotide catabolic process (GO:0009214) | 2.73895253 |
| 129 | indole-containing compound metabolic process (GO:0042430) | 2.73706097 |
| 130 | regulation of neurotransmitter secretion (GO:0046928) | 2.73568908 |
| 131 | cAMP catabolic process (GO:0006198) | 2.72774575 |
| 132 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.72508913 |
| 133 | neuronal ion channel clustering (GO:0045161) | 2.71414161 |
| 134 | intraciliary transport (GO:0042073) | 2.70390947 |
| 135 | regulation of synapse maturation (GO:0090128) | 2.70089599 |
| 136 | dendrite development (GO:0016358) | 2.67729752 |
| 137 | adult behavior (GO:0030534) | 2.67138594 |
| 138 | cell migration in hindbrain (GO:0021535) | 2.67084271 |
| 139 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.66785447 |
| 140 | striatum development (GO:0021756) | 2.65645411 |
| 141 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.65166167 |
| 142 | synaptic transmission (GO:0007268) | 2.64770890 |
| 143 | behavioral response to cocaine (GO:0048148) | 2.63525682 |
| 144 | indolalkylamine metabolic process (GO:0006586) | 2.63451357 |
| 145 | negative regulation of synaptic transmission (GO:0050805) | 2.63362678 |
| 146 | artery development (GO:0060840) | 2.62829468 |
| 147 | glycerophospholipid catabolic process (GO:0046475) | 2.61873560 |
| 148 | negative regulation of astrocyte differentiation (GO:0048712) | 2.60957792 |
| 149 | cilium organization (GO:0044782) | 2.59285461 |
| 150 | telomere maintenance via telomerase (GO:0007004) | 2.58155596 |
| 151 | cilium assembly (GO:0042384) | 2.57524045 |
| 152 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.53459248 |
| 153 | L-fucose catabolic process (GO:0042355) | 2.51886523 |
| 154 | fucose catabolic process (GO:0019317) | 2.51886523 |
| 155 | L-fucose metabolic process (GO:0042354) | 2.51886523 |
| 156 | kynurenine metabolic process (GO:0070189) | 2.51809519 |
| 157 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.50824675 |
| 158 | neurotransmitter catabolic process (GO:0042135) | 2.50048671 |
| 159 | retinal cone cell development (GO:0046549) | 2.49597579 |
| 160 | action potential (GO:0001508) | 2.49471475 |
| 161 | cochlea development (GO:0090102) | 2.49278576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.20749007 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 4.54390114 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.19978947 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.74169756 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.72244807 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.63763713 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.50455446 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.44136815 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37267120 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.32256729 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29860429 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29573082 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.20651849 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.20651849 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16250646 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15394334 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13125845 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.11852012 |
| 19 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.08165168 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.07957041 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06107568 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.03895307 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03412835 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02321440 |
| 25 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97720614 |
| 26 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.97361060 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.89712414 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85216455 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.84831325 |
| 30 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.84714100 |
| 31 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.83183300 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82238308 |
| 33 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80793643 |
| 34 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77514564 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77338912 |
| 36 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72785830 |
| 37 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67629761 |
| 38 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.64726346 |
| 39 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.61002675 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.59223417 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57688474 |
| 42 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54109185 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.53333377 |
| 44 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52156583 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52019023 |
| 46 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.50036207 |
| 47 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.50036207 |
| 48 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.49133679 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49133186 |
| 50 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.48440997 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48121038 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44315426 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44227346 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43842345 |
| 55 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.43538875 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42471092 |
| 57 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41872935 |
| 58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.41683846 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41505960 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40632941 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.39347703 |
| 62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37703868 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37460500 |
| 64 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37023576 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35332156 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34681812 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34602773 |
| 68 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.32986627 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31494786 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28221259 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25658364 |
| 72 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.25387246 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25071974 |
| 74 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24982303 |
| 75 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.24867515 |
| 76 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24180882 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24054343 |
| 78 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23767643 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23413002 |
| 80 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.23053069 |
| 81 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22647257 |
| 82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.20718728 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20718728 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20311568 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19535281 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19526724 |
| 87 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.19517370 |
| 88 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.18196365 |
| 89 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16923744 |
| 90 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16309949 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16076853 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15867780 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15459370 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13439511 |
| 95 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13401992 |
| 96 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13334669 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12793358 |
| 98 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12710473 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12039043 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12007726 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11694896 |
| 102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11407600 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10390262 |
| 104 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09613369 |
| 105 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08715565 |
| 106 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08576002 |
| 107 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07719157 |
| 108 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07463411 |
| 109 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07345693 |
| 110 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.06919375 |
| 111 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06860568 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06807164 |
| 113 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.06684957 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 1.06462500 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05353828 |
| 116 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03758552 |
| 117 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03210980 |
| 118 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03167268 |
| 119 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02785134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.26005982 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.76091852 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.56047692 |
| 4 | MP0009745_abnormal_behavioral_response | 3.33108957 |
| 5 | MP0002064_seizures | 3.08879303 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.01602700 |
| 7 | MP0004270_analgesia | 2.99514855 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.91670856 |
| 9 | MP0009046_muscle_twitch | 2.90445231 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.83868679 |
| 11 | MP0001486_abnormal_startle_reflex | 2.82823234 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.66292640 |
| 13 | MP0002272_abnormal_nervous_system | 2.66242695 |
| 14 | MP0002822_catalepsy | 2.65740105 |
| 15 | MP0002736_abnormal_nociception_after | 2.65030523 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.54032723 |
| 17 | MP0004133_heterotaxia | 2.48621658 |
| 18 | MP0001188_hyperpigmentation | 2.42015265 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.29428957 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.26379383 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.19588484 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.11780601 |
| 23 | MP0005646_abnormal_pituitary_gland | 2.06087618 |
| 24 | MP0003787_abnormal_imprinting | 2.04949753 |
| 25 | MP0001529_abnormal_vocalization | 2.04664955 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 2.00812392 |
| 27 | MP0004142_abnormal_muscle_tone | 1.95260453 |
| 28 | MP0000778_abnormal_nervous_system | 1.94988882 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.90455380 |
| 30 | MP0005409_darkened_coat_color | 1.88004225 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.87615127 |
| 32 | MP0001970_abnormal_pain_threshold | 1.85607443 |
| 33 | MP0002163_abnormal_gland_morphology | 1.78254984 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.74919087 |
| 35 | MP0003195_calcinosis | 1.73355142 |
| 36 | MP0004043_abnormal_pH_regulation | 1.73307277 |
| 37 | MP0004924_abnormal_behavior | 1.70728123 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.70728123 |
| 39 | MP0002184_abnormal_innervation | 1.69022982 |
| 40 | MP0005171_absent_coat_pigmentation | 1.63483612 |
| 41 | MP0004742_abnormal_vestibular_system | 1.58523864 |
| 42 | MP0001984_abnormal_olfaction | 1.57435101 |
| 43 | MP0001905_abnormal_dopamine_level | 1.56381892 |
| 44 | MP0000920_abnormal_myelination | 1.50340825 |
| 45 | MP0003136_yellow_coat_color | 1.46014863 |
| 46 | MP0008569_lethality_at_weaning | 1.41860116 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.39944479 |
| 48 | MP0004885_abnormal_endolymph | 1.37506509 |
| 49 | MP0003879_abnormal_hair_cell | 1.36442746 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.35748566 |
| 51 | MP0000955_abnormal_spinal_cord | 1.35742617 |
| 52 | MP0005379_endocrine/exocrine_gland_phen | 1.34496272 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.33890741 |
| 54 | MP0000427_abnormal_hair_cycle | 1.33753283 |
| 55 | MP0001963_abnormal_hearing_physiology | 1.31611547 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.30797459 |
| 57 | MP0006292_abnormal_olfactory_placode | 1.29786204 |
| 58 | MP0003890_abnormal_embryonic-extraembry | 1.25883569 |
| 59 | MP0004147_increased_porphyrin_level | 1.19559868 |
| 60 | MP0004811_abnormal_neuron_physiology | 1.19398151 |
| 61 | MP0003690_abnormal_glial_cell | 1.17679938 |
| 62 | MP0003633_abnormal_nervous_system | 1.17289731 |
| 63 | MP0002229_neurodegeneration | 1.17061089 |
| 64 | MP0003122_maternal_imprinting | 1.14525974 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.12822624 |
| 66 | MP0003646_muscle_fatigue | 1.10386477 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.10148112 |
| 68 | MP0002938_white_spotting | 1.05734590 |
| 69 | MP0003631_nervous_system_phenotype | 1.05317924 |
| 70 | MP0002102_abnormal_ear_morphology | 1.04359642 |
| 71 | MP0000631_abnormal_neuroendocrine_gland | 1.03934759 |
| 72 | MP0002876_abnormal_thyroid_physiology | 1.02411578 |
| 73 | MP0000647_abnormal_sebaceous_gland | 1.00006432 |
| 74 | MP0002152_abnormal_brain_morphology | 0.99871248 |
| 75 | MP0002751_abnormal_autonomic_nervous | 0.99670280 |
| 76 | MP0000026_abnormal_inner_ear | 0.99072668 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.98633354 |
| 78 | MP0002752_abnormal_somatic_nervous | 0.98622259 |
| 79 | MP0003634_abnormal_glial_cell | 0.95888966 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95540875 |
| 81 | MP0005595_abnormal_vascular_smooth | 0.95416399 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.95138794 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.93813864 |
| 84 | MP0002653_abnormal_ependyma_morphology | 0.93557191 |
| 85 | MP0002928_abnormal_bile_duct | 0.93235667 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.93119322 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.89647046 |
| 88 | MP0008775_abnormal_heart_ventricle | 0.89560859 |
| 89 | MP0003329_amyloid_beta_deposits | 0.88611619 |
| 90 | MP0000383_abnormal_hair_follicle | 0.87489139 |
| 91 | MP0002069_abnormal_eating/drinking_beha | 0.85210652 |
| 92 | MP0003698_abnormal_male_reproductive | 0.83835793 |
| 93 | MP0003938_abnormal_ear_development | 0.83185225 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.82928192 |
| 95 | MP0003632_abnormal_nervous_system | 0.82358653 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.82316744 |
| 97 | MP0008874_decreased_physiological_sensi | 0.81419751 |
| 98 | MP0004858_abnormal_nervous_system | 0.81075577 |
| 99 | MP0002234_abnormal_pharynx_morphology | 0.78867642 |
| 100 | MP0001177_atelectasis | 0.77957949 |
| 101 | MP0004085_abnormal_heartbeat | 0.77102446 |
| 102 | MP0002127_abnormal_cardiovascular_syste | 0.76515744 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.74754588 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.74751623 |
| 105 | MP0005174_abnormal_tail_pigmentation | 0.73980511 |
| 106 | MP0003119_abnormal_digestive_system | 0.71520315 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.70689681 |
| 108 | MP0003861_abnormal_nervous_system | 0.70635008 |
| 109 | MP0001664_abnormal_digestion | 0.70178982 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.69672016 |
| 111 | MP0000372_irregular_coat_pigmentation | 0.69135356 |
| 112 | MP0000566_synostosis | 0.68983813 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.65713921 |
| 114 | MP0008872_abnormal_physiological_respon | 0.65549633 |
| 115 | MP0005410_abnormal_fertilization | 0.62317870 |
| 116 | MP0008260_abnormal_autophagy | 0.60659347 |
| 117 | MP0005253_abnormal_eye_physiology | 0.59159198 |
| 118 | MP0003045_fibrosis | 0.55906990 |
| 119 | MP0003121_genomic_imprinting | 0.55021731 |
| 120 | MP0005195_abnormal_posterior_eye | 0.54074416 |
| 121 | MP0001943_abnormal_respiration | 0.52976825 |
| 122 | MP0002090_abnormal_vision | 0.52962867 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.52279999 |
| 124 | MP0005394_taste/olfaction_phenotype | 0.52059539 |
| 125 | MP0005499_abnormal_olfactory_system | 0.52059539 |
| 126 | MP0010770_preweaning_lethality | 0.51628018 |
| 127 | MP0002082_postnatal_lethality | 0.51628018 |
| 128 | MP0004484_altered_response_of | 0.51062409 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.50874082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.35760820 |
| 2 | Epileptic encephalopathy (HP:0200134) | 5.19924653 |
| 3 | Febrile seizures (HP:0002373) | 4.90141334 |
| 4 | Focal seizures (HP:0007359) | 4.70116808 |
| 5 | Hyperventilation (HP:0002883) | 4.37641295 |
| 6 | Atonic seizures (HP:0010819) | 4.19791174 |
| 7 | Myokymia (HP:0002411) | 4.14513516 |
| 8 | True hermaphroditism (HP:0010459) | 3.82157677 |
| 9 | Pancreatic cysts (HP:0001737) | 3.78565250 |
| 10 | Molar tooth sign on MRI (HP:0002419) | 3.72412955 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.72412955 |
| 12 | Broad-based gait (HP:0002136) | 3.70402236 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.67483391 |
| 14 | Chronic hepatic failure (HP:0100626) | 3.60613887 |
| 15 | Nephronophthisis (HP:0000090) | 3.52099354 |
| 16 | Esophageal atresia (HP:0002032) | 3.51955263 |
| 17 | Dialeptic seizures (HP:0011146) | 3.38499267 |
| 18 | Absence seizures (HP:0002121) | 3.36413804 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.29914502 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.22923620 |
| 21 | Gaze-evoked nystagmus (HP:0000640) | 3.15975432 |
| 22 | Gastrointestinal atresia (HP:0002589) | 3.14393786 |
| 23 | Protruding tongue (HP:0010808) | 3.07601671 |
| 24 | Abnormality of the renal medulla (HP:0100957) | 3.06967167 |
| 25 | Excessive salivation (HP:0003781) | 3.01017163 |
| 26 | Drooling (HP:0002307) | 3.01017163 |
| 27 | Absent/shortened dynein arms (HP:0200106) | 2.94004640 |
| 28 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.94004640 |
| 29 | Genetic anticipation (HP:0003743) | 2.88448157 |
| 30 | Absent speech (HP:0001344) | 2.83114120 |
| 31 | Truncal ataxia (HP:0002078) | 2.82884718 |
| 32 | Blue irides (HP:0000635) | 2.81662207 |
| 33 | Abnormality of the renal cortex (HP:0011035) | 2.79069721 |
| 34 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.77288047 |
| 35 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.77288047 |
| 36 | Supranuclear gaze palsy (HP:0000605) | 2.65522229 |
| 37 | Generalized hypopigmentation of hair (HP:0011358) | 2.64868225 |
| 38 | Abnormality of the corticospinal tract (HP:0002492) | 2.64856831 |
| 39 | Progressive inability to walk (HP:0002505) | 2.60021248 |
| 40 | Dysmetria (HP:0001310) | 2.57420796 |
| 41 | Abnormal hair whorl (HP:0010721) | 2.55715493 |
| 42 | Congenital stationary night blindness (HP:0007642) | 2.53982418 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.52650186 |
| 44 | Cystic liver disease (HP:0006706) | 2.51924727 |
| 45 | Abnormality of the aortic arch (HP:0012303) | 2.51193653 |
| 46 | Abnormal ciliary motility (HP:0012262) | 2.50714425 |
| 47 | Intestinal atresia (HP:0011100) | 2.49110959 |
| 48 | Congenital sensorineural hearing impairment (HP:0008527) | 2.48325510 |
| 49 | Dysdiadochokinesis (HP:0002075) | 2.47722337 |
| 50 | Split foot (HP:0001839) | 2.46881979 |
| 51 | Mutism (HP:0002300) | 2.45433041 |
| 52 | Oligodactyly (hands) (HP:0001180) | 2.44522802 |
| 53 | Status epilepticus (HP:0002133) | 2.44288167 |
| 54 | Attenuation of retinal blood vessels (HP:0007843) | 2.40495966 |
| 55 | Gait imbalance (HP:0002141) | 2.40484043 |
| 56 | Polyphagia (HP:0002591) | 2.40441522 |
| 57 | Hemiparesis (HP:0001269) | 2.40188636 |
| 58 | Fair hair (HP:0002286) | 2.39760312 |
| 59 | Action tremor (HP:0002345) | 2.39610904 |
| 60 | Inability to walk (HP:0002540) | 2.38648190 |
| 61 | Visual hallucinations (HP:0002367) | 2.38521847 |
| 62 | Medial flaring of the eyebrow (HP:0010747) | 2.38263730 |
| 63 | Poor eye contact (HP:0000817) | 2.35878821 |
| 64 | Type II lissencephaly (HP:0007260) | 2.33023066 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.31742533 |
| 66 | Polydipsia (HP:0001959) | 2.31542302 |
| 67 | Abnormal drinking behavior (HP:0030082) | 2.31542302 |
| 68 | Bile duct proliferation (HP:0001408) | 2.28893958 |
| 69 | Abnormal biliary tract physiology (HP:0012439) | 2.28893958 |
| 70 | Clumsiness (HP:0002312) | 2.28452488 |
| 71 | Tubulointerstitial nephritis (HP:0001970) | 2.27702860 |
| 72 | Lissencephaly (HP:0001339) | 2.27166349 |
| 73 | Widely spaced teeth (HP:0000687) | 2.26122505 |
| 74 | Optic nerve hypoplasia (HP:0000609) | 2.25892779 |
| 75 | Abnormality of salivation (HP:0100755) | 2.25222768 |
| 76 | Epileptiform EEG discharges (HP:0011182) | 2.23219138 |
| 77 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.20964583 |
| 78 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.20667114 |
| 79 | Abnormality of the labia minora (HP:0012880) | 2.19823064 |
| 80 | Exotropia (HP:0000577) | 2.17801980 |
| 81 | Gastroesophageal reflux (HP:0002020) | 2.15729236 |
| 82 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.15081272 |
| 83 | Abnormality of binocular vision (HP:0011514) | 2.13752303 |
| 84 | Diplopia (HP:0000651) | 2.13752303 |
| 85 | Spastic gait (HP:0002064) | 2.12997350 |
| 86 | Thickened helices (HP:0000391) | 2.12996208 |
| 87 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.11982247 |
| 88 | Postural instability (HP:0002172) | 2.11757535 |
| 89 | Amblyopia (HP:0000646) | 2.11407259 |
| 90 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.10803438 |
| 91 | Sclerocornea (HP:0000647) | 2.09794534 |
| 92 | Congenital primary aphakia (HP:0007707) | 2.09232894 |
| 93 | Fetal akinesia sequence (HP:0001989) | 2.06943161 |
| 94 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.06920499 |
| 95 | Poor coordination (HP:0002370) | 2.05303145 |
| 96 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.03191620 |
| 97 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.03191620 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 2.03007447 |
| 99 | Scanning speech (HP:0002168) | 2.02937037 |
| 100 | Renal cortical cysts (HP:0000803) | 2.02913102 |
| 101 | Limb dystonia (HP:0002451) | 2.02515188 |
| 102 | EEG with generalized epileptiform discharges (HP:0011198) | 2.01415439 |
| 103 | Abnormal social behavior (HP:0012433) | 2.00554825 |
| 104 | Impaired social interactions (HP:0000735) | 2.00554825 |
| 105 | Postaxial hand polydactyly (HP:0001162) | 1.96792805 |
| 106 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96157072 |
| 107 | Esotropia (HP:0000565) | 1.93134986 |
| 108 | Retinal dysplasia (HP:0007973) | 1.92785924 |
| 109 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.92471886 |
| 110 | Akinesia (HP:0002304) | 1.90407280 |
| 111 | Anxiety (HP:0000739) | 1.89757505 |
| 112 | Postaxial foot polydactyly (HP:0001830) | 1.89296926 |
| 113 | Anencephaly (HP:0002323) | 1.89038916 |
| 114 | Genital tract atresia (HP:0001827) | 1.88779422 |
| 115 | Ankle clonus (HP:0011448) | 1.88092342 |
| 116 | Congenital hepatic fibrosis (HP:0002612) | 1.87587461 |
| 117 | Hemiplegia (HP:0002301) | 1.87250641 |
| 118 | Specific learning disability (HP:0001328) | 1.86894779 |
| 119 | Pachygyria (HP:0001302) | 1.86514737 |
| 120 | Occipital encephalocele (HP:0002085) | 1.86344524 |
| 121 | Vaginal atresia (HP:0000148) | 1.83950393 |
| 122 | Tubular atrophy (HP:0000092) | 1.83799204 |
| 123 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.83194411 |
| 124 | Cerebral inclusion bodies (HP:0100314) | 1.83148873 |
| 125 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.81948806 |
| 126 | Hypsarrhythmia (HP:0002521) | 1.81581430 |
| 127 | Tented upper lip vermilion (HP:0010804) | 1.81094691 |
| 128 | Narrow forehead (HP:0000341) | 1.79137052 |
| 129 | Aqueductal stenosis (HP:0002410) | 1.78946257 |
| 130 | Neuronal loss in central nervous system (HP:0002529) | 1.78075934 |
| 131 | Bowel incontinence (HP:0002607) | 1.77397021 |
| 132 | Tubulointerstitial abnormality (HP:0001969) | 1.76050993 |
| 133 | Cerebellar dysplasia (HP:0007033) | 1.74513154 |
| 134 | Large for gestational age (HP:0001520) | 1.72829868 |
| 135 | Short foot (HP:0001773) | 1.71831501 |
| 136 | Polyuria (HP:0000103) | 1.71637720 |
| 137 | Hip dysplasia (HP:0001385) | 1.71109574 |
| 138 | Narrow nasal bridge (HP:0000446) | 1.70304674 |
| 139 | Decreased central vision (HP:0007663) | 1.69687740 |
| 140 | Thyroid-stimulating hormone excess (HP:0002925) | 1.69492080 |
| 141 | Stereotypic behavior (HP:0000733) | 1.69448141 |
| 142 | Depression (HP:0000716) | 1.69237165 |
| 143 | Sleep apnea (HP:0010535) | 1.69170802 |
| 144 | Stomach cancer (HP:0012126) | 1.68754767 |
| 145 | Bradycardia (HP:0001662) | 1.68492904 |
| 146 | Sensory axonal neuropathy (HP:0003390) | 1.68479746 |
| 147 | Atelectasis (HP:0100750) | 1.67964049 |
| 148 | Abnormal large intestine physiology (HP:0012700) | 1.67180479 |
| 149 | Lower limb muscle weakness (HP:0007340) | 1.66974438 |
| 150 | Autism (HP:0000717) | 1.64090310 |
| 151 | Peripheral hypomyelination (HP:0007182) | 1.63952027 |
| 152 | Metabolic alkalosis (HP:0200114) | 1.63784291 |
| 153 | Generalized myoclonic seizures (HP:0002123) | 1.62652390 |
| 154 | Intention tremor (HP:0002080) | 1.61190041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.99619033 |
| 2 | TAOK2 | 4.93872002 |
| 3 | CASK | 4.79489723 |
| 4 | MAP4K2 | 4.69828589 |
| 5 | NTRK3 | 4.55269121 |
| 6 | TNIK | 4.45895019 |
| 7 | EPHA4 | 3.61976569 |
| 8 | MAP2K6 | 3.21734935 |
| 9 | TLK1 | 2.93317482 |
| 10 | MARK1 | 2.71382991 |
| 11 | MAP2K7 | 2.69913072 |
| 12 | MAP3K4 | 2.36267084 |
| 13 | NTRK2 | 2.26166607 |
| 14 | MAPK13 | 2.00974703 |
| 15 | RIPK4 | 1.88436450 |
| 16 | GRK7 | 1.76289330 |
| 17 | MAP3K9 | 1.74032064 |
| 18 | PRPF4B | 1.72361271 |
| 19 | MAP3K5 | 1.66921271 |
| 20 | OXSR1 | 1.55059900 |
| 21 | WNK4 | 1.54022347 |
| 22 | SIK2 | 1.40862018 |
| 23 | PNCK | 1.40063269 |
| 24 | MAP3K12 | 1.39486505 |
| 25 | ACVR1B | 1.34850280 |
| 26 | ADRBK2 | 1.34473295 |
| 27 | STK39 | 1.34413369 |
| 28 | FES | 1.32015292 |
| 29 | PKN1 | 1.27449149 |
| 30 | CDK3 | 1.27252431 |
| 31 | TAOK3 | 1.25874469 |
| 32 | MINK1 | 1.23744677 |
| 33 | MAP2K4 | 1.22665975 |
| 34 | CAMK2A | 1.18616000 |
| 35 | PLK2 | 1.18539234 |
| 36 | SIK3 | 1.17476146 |
| 37 | BMPR2 | 1.17284149 |
| 38 | NEK6 | 1.17066379 |
| 39 | MUSK | 1.12670964 |
| 40 | CAMK2B | 1.12342616 |
| 41 | PAK3 | 1.12272721 |
| 42 | AKT3 | 1.11893270 |
| 43 | GRK1 | 1.09187110 |
| 44 | CDK5 | 1.07977428 |
| 45 | SGK494 | 1.07926939 |
| 46 | SGK223 | 1.07926939 |
| 47 | CAMKK2 | 1.07284813 |
| 48 | DAPK2 | 1.00053700 |
| 49 | FGFR2 | 0.97084557 |
| 50 | SGK2 | 0.96580038 |
| 51 | PIK3CA | 0.96373150 |
| 52 | NUAK1 | 0.94891908 |
| 53 | GRK5 | 0.93781921 |
| 54 | CAMK1G | 0.93419044 |
| 55 | INSRR | 0.91058215 |
| 56 | CDK19 | 0.90316938 |
| 57 | BMPR1B | 0.88646120 |
| 58 | CSNK1G1 | 0.88440887 |
| 59 | PAK6 | 0.87772871 |
| 60 | DYRK2 | 0.86697618 |
| 61 | PRKCG | 0.85612819 |
| 62 | EPHA3 | 0.85365078 |
| 63 | MAP3K13 | 0.83033122 |
| 64 | MAPK15 | 0.82549417 |
| 65 | FGR | 0.82449516 |
| 66 | BCR | 0.82012178 |
| 67 | UHMK1 | 0.81539784 |
| 68 | CAMK1 | 0.81448340 |
| 69 | MAP3K6 | 0.79876434 |
| 70 | NTRK1 | 0.79176550 |
| 71 | MARK2 | 0.79084470 |
| 72 | PRKCE | 0.78904753 |
| 73 | SGK1 | 0.78066706 |
| 74 | ZAK | 0.76234838 |
| 75 | YES1 | 0.75735723 |
| 76 | ARAF | 0.72931877 |
| 77 | WNK1 | 0.69292696 |
| 78 | CSNK1G2 | 0.67980705 |
| 79 | DAPK1 | 0.65958984 |
| 80 | PTK2B | 0.65871970 |
| 81 | KSR1 | 0.65155193 |
| 82 | CAMK2D | 0.64747240 |
| 83 | ERBB3 | 0.64607895 |
| 84 | MAPKAPK5 | 0.62934805 |
| 85 | STK16 | 0.62329696 |
| 86 | DYRK1A | 0.60998506 |
| 87 | PHKG2 | 0.58590323 |
| 88 | PHKG1 | 0.58590323 |
| 89 | CAMKK1 | 0.58238550 |
| 90 | STK38L | 0.56815965 |
| 91 | PRKG1 | 0.56435053 |
| 92 | MAPK12 | 0.54767423 |
| 93 | STK38 | 0.53739938 |
| 94 | SGK3 | 0.52591747 |
| 95 | CAMK4 | 0.51857423 |
| 96 | STK11 | 0.51724867 |
| 97 | MAPKAPK3 | 0.50989813 |
| 98 | NME1 | 0.50706833 |
| 99 | WNK3 | 0.49971725 |
| 100 | TNK2 | 0.49130474 |
| 101 | MAPK7 | 0.49122742 |
| 102 | CAMK2G | 0.48342366 |
| 103 | PRKCZ | 0.47635222 |
| 104 | CDK18 | 0.45972561 |
| 105 | CLK1 | 0.45882514 |
| 106 | MKNK2 | 0.45770544 |
| 107 | PRKCQ | 0.45639226 |
| 108 | TXK | 0.45069150 |
| 109 | CAMK1D | 0.44789270 |
| 110 | ERBB4 | 0.44335911 |
| 111 | PRKCH | 0.43433267 |
| 112 | BRD4 | 0.42388099 |
| 113 | BRAF | 0.42119226 |
| 114 | CDK15 | 0.41874686 |
| 115 | ADRBK1 | 0.41445035 |
| 116 | PRKAA1 | 0.41016750 |
| 117 | CSNK1A1L | 0.40895363 |
| 118 | CSNK1D | 0.40748551 |
| 119 | FYN | 0.39238777 |
| 120 | CCNB1 | 0.38964871 |
| 121 | IRAK2 | 0.38043384 |
| 122 | PRKACA | 0.38038618 |
| 123 | CSNK1G3 | 0.37714941 |
| 124 | PINK1 | 0.37253555 |
| 125 | RPS6KA3 | 0.36431888 |
| 126 | EIF2AK2 | 0.35949277 |
| 127 | PRKACB | 0.33243385 |
| 128 | TGFBR1 | 0.33219158 |
| 129 | TRIM28 | 0.32350736 |
| 130 | CSNK1A1 | 0.32030990 |
| 131 | VRK1 | 0.29132181 |
| 132 | PLK4 | 0.28984284 |
| 133 | TIE1 | 0.28979554 |
| 134 | FER | 0.28595964 |
| 135 | PRKCA | 0.25556177 |
| 136 | PRKCB | 0.20449300 |
| 137 | IRAK1 | 0.19803033 |
| 138 | TYRO3 | 0.18882261 |
| 139 | DYRK3 | 0.16449391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.73309906 |
| 2 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.07184103 |
| 3 | Morphine addiction_Homo sapiens_hsa05032 | 2.87027052 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.83833707 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.81796688 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.54993958 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.50639365 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.43214058 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25821330 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.22562447 |
| 11 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.21289757 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.20097200 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.16276515 |
| 14 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.06267260 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.99150061 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.97045504 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91721467 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.82314588 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.77867038 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74903415 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.70289495 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.69870876 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.69870850 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.63735866 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.57423249 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.53028302 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50787797 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.42566877 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39217862 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39181095 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39137739 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35765864 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.32607017 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.31522650 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26645650 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25615273 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24587636 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.20317528 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.20051494 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18562475 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15824958 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13958992 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13055296 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10955736 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08266931 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06700233 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05570384 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04306168 |
| 49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.02771172 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01360298 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 0.96786325 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96773559 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94591890 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93596125 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93467190 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92242173 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90638790 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87067044 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85820805 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83526090 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83257565 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83008718 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82635553 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81900927 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81754420 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80760202 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77518430 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77380913 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76744183 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76083519 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75742018 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75653268 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75614310 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.75200545 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73794867 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73248633 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.73212573 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73159573 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73013647 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72494093 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71763931 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70094082 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67805788 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67475152 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66940904 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64021369 |
| 87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63933400 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63168841 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63009780 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62286910 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61049708 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60096309 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58734828 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57419130 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57296334 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55835811 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.55756192 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55414784 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54123962 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53838715 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52695242 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49441775 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47725822 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47678309 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.47393662 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46213611 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.45848510 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45589463 |
| 109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44482659 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44471009 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.44214436 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43916564 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43724048 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43579563 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43557575 |
| 116 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42912060 |
| 117 | Alcoholism_Homo sapiens_hsa05034 | 0.40661923 |
| 118 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40573183 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39164089 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38097767 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35447894 |
| 122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34967707 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30831208 |
| 124 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29195264 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.28404961 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27948015 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26382639 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25687668 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.24324559 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23647105 |
| 131 | Melanoma_Homo sapiens_hsa05218 | 0.22148781 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.21557282 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21013169 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.19515373 |

